Valspodar Completed Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002937Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
NCT00002826Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer